Steroid myopathy is a non-inflammatory toxic myopathy that occurs as side effect of exogenous and endogenous glucocorticoid excess. The purpose of this review is to examine issues that limit our understanding of this myopathy with respect to nosology, etiopathogenesis, conditioning factors, and muscle fiber selectivity. We suggest that if more data were available on these issues, the understanding of steroid myopathy would be enhanced substantially, thus allowing an early detection of its occurrence (before the appearance of clinical or laboratory signs) and a proper treatment of the patients.
Steroid myopathy: some unresolved issues
MINETTO, Marco Alessandro;LANFRANCO, Fabio;MOTTA, GIOVANNA;ALLASIA, Stefano;ARVAT, Emanuela;
2011-01-01
Abstract
Steroid myopathy is a non-inflammatory toxic myopathy that occurs as side effect of exogenous and endogenous glucocorticoid excess. The purpose of this review is to examine issues that limit our understanding of this myopathy with respect to nosology, etiopathogenesis, conditioning factors, and muscle fiber selectivity. We suggest that if more data were available on these issues, the understanding of steroid myopathy would be enhanced substantially, thus allowing an early detection of its occurrence (before the appearance of clinical or laboratory signs) and a proper treatment of the patients.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Minetto et al. JEI 2011.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
338.65 kB
Formato
Adobe PDF
|
338.65 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.